Progress in the development of RBC substitutes

被引：92

作者：

Stowell, CP

Levin, J

Spiess, BD

Winslow, RM

机构：

[1] Massachusetts Gen Hosp, Blood Transfus Serv, Boston, MA 02114 USA

[2] Univ Calif San Francisco, Sch Med, Dept Lab Med, San Francisco, CA 94143 USA

[3] Virginia Commonwealth Univ, Med Coll Virginia, Div Cardiothorac Anesthesia, Richmond, VA 23298 USA

[4] Sangart Inc, San Diego, CA USA

来源：

TRANSFUSION | 2001年 / 41卷 / 02期

关键词：

D O I：

10.1046/j.1537-2995.2001.41020287.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：287 / 299

页数：13

共 94 条

[1]

ADAMSON JG, 1998, RED BLOOD CELL SUBST, P335

[2] Hemoglobin-based blood substitutes: oxygen carriers, pressor agents, or oxidants? [J].

Alayash, AI .

NATURE BIOTECHNOLOGY, 1999, 17 (06) :545-549

[3]

*ALL PHARM CORP, 2001, AABB WKLY REP, V7, P5

[4]

Blauth C, 1989, Eur J Cardiothorac Surg, V3, P135, DOI 10.1016/1010-7940(89)90091-2

[5]

Blauth C, 1989, EUR J CARDIO-THORAC, V3, P139

[6]

BLAUTH CI, 1988, J THORAC CARDIOV SUR, V95, P668

[7]

BURTON TM, 1998, WALL STREET J 0603, pB9

[8] IMMUNOLOGICAL EFFECTS OF HEMOGLOBIN, ENCAPSULATED HEMOGLOBIN, POLYHEMOGLOBIN AND CONJUGATED HEMOGLOBIN USING DIFFERENT IMMUNIZATION SCHEDULES [J].

CHANG, TMS ;

LISTER, C ;

NISHIYA, T ;

VARMA, R .

BIOMATERIALS ARTIFICIAL CELLS AND IMMOBILIZATION BIOTECHNOLOGY, 1992, 20 (2-4) :611-618

[9]

CHANG TMS, 1997, BLOOD SUBSTITUTES PR, V1

[10]

CHATTERJEE R, 1986, J BIOL CHEM, V261, P9929

← 1 2 3 4 5 6 7 8 9 10 →